Gennex Laboratories Ltd (GNXL)

Currency in INR
12.21
-0.17(-1.37%)
Delayed Data·
GNXL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GNXL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.2112.61
52 wk Range
11.1529.00
Key Statistics
Bid/Ask
12.21 / 12.26
Prev. Close
12.38
Open
12.4
Day's Range
12.21-12.61
52 wk Range
11.15-29
Volume
40.05K
Average Volume (3m)
452.82K
1-Year Change
-12.38%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNXL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Gennex Laboratories Ltd Company Profile

Gennex Laboratories Limited engages in manufacturing and selling of bulk drugs, intermediates, and biotech products. The company offers Guaifenesin, Methocarbamol, Fexifenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl, and Allopurinol. It operates in India, Colombia, Egypt, Germany, Iran, Peru, Saudi Arabia, Spain, Thailand, and Vietnam. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Employees
129
Market
India

Compare GNXL to Peers and Sector

Metrics to compare
GNXL
Peers
Sector
Relationship
P/E Ratio
17.5x12.3x−0.5x
PEG Ratio
0.610.150.00
Price/Book
1.5x1.2x2.6x
Price / LTM Sales
2.0x1.7x3.3x
Upside (Analyst Target)
-10.9%43.4%
Fair Value Upside
Unlock4.0%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
441.60M / --
EPS Revisions
Last 90 days

GNXL Income Statement

People Also Watch

131.09
UNBK
-1.03%
1,002.00
AMAL
-0.51%
392.00
DHAB
+1.15%
1,460.00
MORC
-0.33%

FAQ

What Stock Exchange Does Gennex Laboratories Trade On?

Gennex Laboratories is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Gennex Laboratories?

The stock symbol for Gennex Laboratories is "GNXL."

What Is the Gennex Laboratories Market Cap?

As of today, Gennex Laboratories market cap is 2.78B.

What Is Gennex Laboratories's Earnings Per Share (TTM)?

The Gennex Laboratories EPS (TTM) is 0.80.

From a Technical Analysis Perspective, Is GNXL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Gennex Laboratories Stock Split?

Gennex Laboratories has split 1 times.

How Many Employees Does Gennex Laboratories Have?

Gennex Laboratories has 129 employees.

What is the current trading status of Gennex Laboratories (GNXL)?

As of 08 Aug 2025, Gennex Laboratories (GNXL) is trading at a price of 12.21, with a previous close of 12.38. The stock has fluctuated within a day range of 12.21 to 12.61, while its 52-week range spans from 11.15 to 29.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.